Status:
COMPLETED
Craving to Biologics Used in Severe Asthma
Lead Sponsor:
Frisius Medisch Centrum
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Some patients treated with biologics for severe asthma experience a craving to the next biological administration. This phenomenon has never been described before. In this study, the researchers aim t...
Detailed Description
Recent research by Kroes and colleagues on omalizumab levels has shown that approximately half of patients on long-term omalizumab therapy (\>4 months) experience a subjective craving for the next dos...
Eligibility Criteria
Inclusion
- Treated with a biologic for severe asthma in the Medical Centre Leeuwarden for more than 4 months
Exclusion
- Not speaking Dutch
Key Trial Info
Start Date :
December 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05426538
Start Date
December 10 2021
End Date
August 1 2022
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Centre Leeuwarden
Leeuwarden, Provincie Friesland, Netherlands, 8934AD